Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-02-02-2003
Volume27
Issue 2

PhRMA Perspectives on Drug Substance Regulatory Filing Issues

Author(s):

Michael Mitchell

The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.

External Link - article-45872.pdf

Articles in this issue
A Stress Testing Benchmarking Study
Cleanroom Pressurization Methodology
PhRMA Perspectives on Drug Substance Regulatory Filing Issues
Manufacturing Capability Key to Global Health Advances
February 2003
Outsourcing Outlook

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave A Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, CSO, AustinPx
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 15th 2025

FDA Commissioner Applauds Florida Restriction on 7-OH Opioids

Susan Haigney
Drug Solutions Podcast: Sustainable Solutions for Biopharma
August 15th 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
Site Logo
August 15th 2025

Decentralized Trials: The Value of Direct-to-Patient & Pharmacy-Led Solutions

Catalent
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
August 15th 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
Site Logo
August 15th 2025

European Clinical Supply Planning – Balancing Cost, Flexibility & Time

Catalent
Site Logo
August 15th 2025

Optimizing Clinical Trials in China with Strategic Solutions for Supply Chain Challenges

Catalent